TABLE 4.
Results of network meta‐analysis of wound healing cases.
| Intervention measures | 120 μg/cm2 repifermin | 60 μg/cm2 repifermin | AFG | Antiseptic ointment dressing | APG | Aurix | HPL | LeucoPatch | PPP | PRF | PRP | PRP injection | CT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 μg/cm2 repifermin | 0 | ||||||||||||
| 60 μg/cm2 repifermin | −0.29 (−2.13, 1.52) | 0 | |||||||||||
| AFG | 16.22 (−40.08, 73.89) | 16.52 (−39.73, 74.2) | 0 | ||||||||||
| Antiseptic ointment dressing | −0.34 (−3.41, 2.53) | −0.05 (−3.12, 2.86) | −16.57 (−74.3, 39.73) | 0 | |||||||||
| APG | −2.08 (−4.85, −0.19) | −1.78 (−4.55, 0.1) | −18.42 (−76.18, 37.89) | −1.76 (−4.79, 0.73) | 0 | ||||||||
| Aurix | −1.16 (−3.39, 1.1) | −0.86 (−3.1, 1.39) | −17.31 (−75, 38.83) | −0.81 (−3.46, 1.97) | 0.93 (−0.63, 3.31) | 0 | |||||||
| HPL | −0.46 (−3.14, 2.24) | −0.17 (−2.82, 2.53) | −16.65 (−74.32, 39.63) | −0.11 (−3.13, 3.08) | 1.64 (−0.43, 4.5) | 0.7 (−1.66, 3.08) | 0 | ||||||
| LeucoPatch | −1.04 (−3.61, 1.55) | −0.75 (−3.29, 1.83) | −17.22 (−74.9, 39) | −0.68 (−3.58, 2.38) | 1.05 (−0.83, 3.8) | 0.13 (−2.12, 2.37) | −0.57 (−3.26, 2.09) | 0 | |||||
| PPP | 0.23 (−2.85, 3.11) | 0.52 (−2.54, 3.42) | −16.04 (−73.78, 40.37) | 0.57 (−2.47, 3.61) | 2.34 (−0.16, 5.39) | 1.39 (−1.43, 4.03) | 0.69 (−2.51, 3.69) | 1.27 (−1.8, 4.16) | 0 | ||||
| PRF | −6.44 (−70.84, 49.94) | −6.14 (−70.53, 50.2) | −21.91 (−116.97, 72.28) | −6.07 (−70.63, 50.22) | −4.18 (−68.55, 52.1) | −5.29 (−69.71, 50.9) | −6.03 (−70.44, 50.22) | −5.42 (−69.81, 50.89) | −6.68 (−71.18, 49.71) | 0 | |||
| PRP | −1.44 (−3.66, 0.5) | −1.15 (−3.36, 0.82) | −17.69 (−75.41, 38.5) | −1.11 (−3.29, 1) | 0.66 (−0.86, 2.67) | −0.29 (−2.07, 1.24) | −0.98 (−3.33, 1.11) | −0.4 (−2.63, 1.52) | −1.67 (−3.88, 0.44) | 4.98 (−51.24, 69.38) | 0 | ||
| PRP injection | −2.07 (−4.74, 0.47) | −1.76 (−4.42, 0.76) | −18.28 (−75.93, 38) | −1.71 (−4.55, 1.13) | 0.05 (−2.07, 2.7) | −0.9 (−3.25, 1.3) | −1.59 (−4.41, 1.03) | −1.02 (−3.69, 1.49) | −2.28 (−5.16, 0.58) | 4.33 (−51.83, 68.64) | −0.6 (−2.45, 1.3) | 0 | |
| CT | −0.37 (−2.19, 1.45) | −0.08 (−1.89, 1.77) | −16.56 (−74.2, 39.64) | −0.02 (−2.34, 2.42) | 1.73 (0.61, 3.6) | 0.79 (−0.53, 2.12) | 0.09 (−1.87, 2.05) | 0.66 (−1.14, 2.48) | −0.6 (−2.92, 1.87) | 6.11 (−50.12, 70.46) | 1.08 (0.17, 2.21) | 1.69 (−0.09, 3.64) | 0 |
Abbreviations: AFG, autologous fibrin gel; APG, autologous platelet gel; Aurix, aurix gel; CT, conventional treatment; GF, growth factor; HPL, autologous platelet lysate; PPP, platelet‐poor plasma; PRF, platelet‐rich fibrin; PRF injection, injectable platelet‐rich fibrin; PRP, platelet‐rich plasma.